Evolution of clinical features in possible DLB depending on FP-CIT SPECT result

Neurology. 2016 Sep 6;87(10):1045-51. doi: 10.1212/WNL.0000000000003076. Epub 2016 Aug 10.

Abstract

Objective: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core and suggestive features in patients with possible DLB over time depending on the (123)I-FP-CIT SPECT scan result.

Methods: A total of 187 patients with possible DLB (dementia plus one core or one suggestive feature) were randomized to have dopamine transporter imaging or to follow-up without scan. DLB features were compared at baseline and at 6-month follow-up according to imaging results and follow-up diagnosis.

Results: For the whole cohort, the baseline frequency of parkinsonism was 30%, fluctuations 29%, visual hallucinations 24%, and REM sleep behavior disorder 17%. Clinician-rated presence of parkinsonism at baseline was significantly (p = 0.001) more frequent and Unified Parkinson's Disease Rating Scale (UPDRS) score at baseline was significantly higher (p = 0.02) in patients with abnormal imaging. There was a significant increase in UPDRS score in the abnormal scan group over time (p < 0.01). There was relatively little evolution of the rest of the DLB features regardless of the imaging result.

Conclusions: In patients with possible DLB, apart from UPDRS score, there was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging. Only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia.

Publication types

  • Clinical Trial, Phase IV
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Brain / diagnostic imaging
  • Disease Progression
  • Europe
  • Female
  • Follow-Up Studies
  • Hallucinations / diagnostic imaging
  • Hallucinations / epidemiology
  • Hallucinations / physiopathology
  • Humans
  • Lewy Body Disease / diagnostic imaging*
  • Lewy Body Disease / epidemiology
  • Lewy Body Disease / physiopathology*
  • Male
  • Mental Status Schedule
  • Parkinsonian Disorders / diagnostic imaging
  • Parkinsonian Disorders / epidemiology
  • Parkinsonian Disorders / physiopathology
  • REM Sleep Behavior Disorder / diagnostic imaging
  • REM Sleep Behavior Disorder / epidemiology
  • REM Sleep Behavior Disorder / physiopathology
  • Radiopharmaceuticals
  • Severity of Illness Index
  • Tomography, Emission-Computed, Single-Photon
  • Tropanes

Substances

  • Radiopharmaceuticals
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane